Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone844-427-4742
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$237.11 million
Profitability
Miscellaneous
Employees300
Next Earnings DateN/A
OptionableOptionable
Aphria (TSE:APHA) Frequently Asked Questions
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."
What price target have analysts set for APHA?
2 equities research analysts have issued 1 year price targets for Aphria's shares. Their predictions range from C$7.00 to C$31.00. On average, they expect Aphria's stock price to reach C$16.60 in the next twelve months. View Analyst Price Targets for Aphria.
What is the consensus analysts' recommendation for Aphria?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria.
Has Aphria been receiving favorable news coverage?
Media headlines about APHA stock have trended somewhat negative this week, InfoTrie reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aphria earned a news impact score of -1.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Aphria.
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Aurora Cannabis (ACB), Hikma Pharmaceuticals (HIK), Evotec (EVT), Hexo (HEXO), HEXO (HEXO), Knight Therapeutics (GUD), Green Organic Dutchman (TGOD), OrganiGram (OGI), Supreme Cannabis (FIRE), HLS Therapeutics (HLS), Flowr (FLWR), Benchmark (BMK), CannTrust (TRST), ICC Labs (ICC) and Shield Therapeutics (STX).
What other stocks do shareholders of Aphria own?
Who are Aphria's key executives?
Aphria's management team includes the folowing people:
- Mr. Carl A. Merton, Chief Financial Officer
- Ms. Megan McCrae, VP of Marketing
- Mr. Irwin D. Simon, Interim CEO & Chairman
- Mr. Jakob Ripshtein, Pres
- Mr. Brett D. Marchand, Sr. VP of Operations
How do I buy shares of Aphria?
Shares of APHA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How big of a company is Aphria?
What is Aphria's official website?
How can I contact Aphria?
Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742.
MarketBeat Community Rating for Aphria (TSE APHA)
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APHA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
